Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases

Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice

(2019) Graham J. Britton et al.   IMMUNITY

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis

(2019) Samuel P. Costello et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis

(2019) Erola Astó et al.   Nutrients

The Alternate Consumption of Quercetin and Alliin in the Traditional Asian Diet Reshaped Microbiota and Altered Gene Expression of Colonic Epithelial Cells in Rats

(2019) Juntong Yu et al.   JOURNAL OF FOOD SCIENCE

Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-based Therapies for Inflammatory Bowel Diseases

(2019) Louis J. Cohen et al.   GASTROENTEROLOGY

Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis

(2019) Lasha Gogokhia et al.   Cell Host & Microbe

Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis

(2019) Xiao Ding et al.   DRUG SAFETY

623 – Ser-287, an Investigational Microbiome Therapeutic, Induces Widespread Transcriptional Changes Related to Clinical Remission in a Placebo-Controlled, Double-Blind Randomized Trial (Seres-101) in Patients with Active Mild-To-Moderate Ulcerative Colitis

(2019) Liyang Diao et al.   GASTROENTEROLOGY

377 – Protective and Potentially Aggressive Bacterial Species Occur Simultaneously in Healthy Hosts

(2019) Bo Liu et al.   GASTROENTEROLOGY

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

(2019) Jason Lloyd-Price et al.   NATURE

Turmeric Extract: Potential Use as a Prebiotic and Anti-Inflammatory Compound?

(2019) Fariba Ghiamati Yazdi et al.   PLANT FOODS FOR HUMAN NUTRITION

Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases

(2019) Konrad Aden et al.   GASTROENTEROLOGY

Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial

(2019) Arie Levine et al.   GASTROENTEROLOGY

Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10–producing regulatory B cells

(2019) Yoshiyuki Mishima et al.   JOURNAL OF CLINICAL INVESTIGATION

Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy

(2019) Vadim Dubinsky et al.   GASTROENTEROLOGY

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

(2019) Zachariah DeFilipp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species

(2019) Lohith Kunyeit et al.   mBio

The effect of 2′-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose

(2019) Krista Salli et al.   Scientific Reports

Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration

(2018) Bjoern O. Schroeder et al.   Cell Host & Microbe

Tu1844 - IL-10-Independent Protective Activities of Human-Derived Clostridium Strains in Experimental Colitis

(2018) Akihiko Oka et al.   GASTROENTEROLOGY

85 - SER-287, an Investigational Microbiome Therapeutic, Induces Remission and Endoscopic Improvement in a Placebo-Controlled, Double-Blind Randomized Trial in Patients with Active Mild-to-Moderate Ulcerative Colitis

(2018) Misra Bharat et al.   GASTROENTEROLOGY

Tu2019 - Engraftment of Ser-287, an Investigational Microbiome Therapeutic, is Related to Clinical Remission in a Placebo-Controlled, Double-Blind Randomized Trial (Seres-101) in Patients with Active Mild to Moderate Ulcerative Colitis (UC)

(2018) Sheri Simmons et al.   GASTROENTEROLOGY

Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease

(2018) Alka Goyal et al.   INFLAMMATORY BOWEL DISEASES

Evidence-based clinical practice guidelines for inflammatory bowel disease

(2018) Katsuyoshi Matsuoka et al.   JOURNAL OF GASTROENTEROLOGY

Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice

(2018) Baoren Zhang et al.   Journal of Translational Medicine

Remodeling of the Candida glabrata cell wall in the gastrointestinal tract affects the gut microbiota and the immune response

(2018) Rogatien Charlet et al.   Scientific Reports

Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study

(2018) Thomas Bazin et al.   Scientific Reports

New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches

(2018) J. Alard et al.   Beneficial Microbes

Genetic Analysis of Human Norovirus Strains in Japan in 2016–2017

(2018) Koo Nagasawa et al.   Frontiers in Microbiology

Risk factors associated with Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis

(2018) Bhairavi Balram et al.   Journal of Crohns & Colitis

Precision editing of the gut microbiota ameliorates colitis

(2018) Wenhan Zhu et al.   NATURE

Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis

(2018) Ho Pan Sham et al.   Frontiers in Immunology

Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn’s disease

(2018) Pan Li et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

American Gastroenterological Association Institute Guideline on the Management of Mild-to-Moderate Ulcerative Colitis

(2018) Cynthia W. Ko et al.   GASTROENTEROLOGY

Murine Adherent and Invasive E. coli Induces Chronic Inflammation and Immune Responses in the Small and Large Intestines of Monoassociated IL-10-/- Mice Independent of Long Polar Fimbriae Adhesin A

(2018) Julia M Schmitz et al.   INFLAMMATORY BOWEL DISEASES

The clinical effects of probiotics for inflammatory bowel disease

(2018) Kai Jia et al.   MEDICINE

Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches

(2017) R. Balfour Sartor et al.   GASTROENTEROLOGY

Table of Contents

(2017)   GASTROENTEROLOGY

Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis

(2017) Dai Ishikawa et al.   INFLAMMATORY BOWEL DISEASES

Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis

(2017) Vinita Jacob et al.   INFLAMMATORY BOWEL DISEASES

Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review

(2017) Mahboube Ganji-Arjenaki et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

(2017) Sudarshan Paramsothy et al.   Journal of Crohns & Colitis

Is intensity the solution for FMT in ulcerative colitis?

(2017) Britta Siegmund   LANCET

Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis

(2017) Ahmet Uygun et al.   MEDICINE

Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation

(2017) David T Riglar et al.   NATURE BIOTECHNOLOGY

Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation

(2017) Koji Atarashi et al.   SCIENCE

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

(2017) Mariana X. Byndloss et al.   SCIENCE

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

(2017) Bertrand Routy et al.   SCIENCE

Inulin-type fructan degradation capacity of Clostridium cluster IV and XIVa butyrate-producing colon bacteria and their associated metabolic outcomes

(2017) F. Moens et al.   Beneficial Microbes

Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm

(2016) J. P. Segal et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Fecal Microbiota Transfer in Patients With Chronic Antibiotic-Refractory Pouchitis

(2016) Andreas Stallmach et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study

(2016) Vincenzo Davide Palumbo et al.   BIOMEDICAL PAPERS-OLOMOUC

Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora

(2016) Yao Wei et al.   BMC MICROBIOLOGY

Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans

(2016) Ron Sender et al.   CELL

Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of Salmonella

(2016) Fabian Rivera-Chávez et al.   Cell Host & Microbe

Clostridium difficile Infection

(2016) Abhik Roy et al.   INFLAMMATORY BOWEL DISEASES

Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohnʼs Disease

(2016) Byron P. Vaughn et al.   INFLAMMATORY BOWEL DISEASES

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation

(2016) Hilary P. Browne et al.   NATURE

Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center

(2016) Chinonyelum Obih et al.   NUTRITION

Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis

(2016) Jinpei Dong et al.   PLoS One

Effect of probiotics (Lactobacillus plantarum 299 plus Bifidobacterium Cure21) in patients with poor ileal pouch function: a randomised controlled trial

(2016) J. Bengtsson et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Prebiotics and synbiotics in ulcerative colitis

(2016) Axel Laurell et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Durable coexistence of donor and recipient strains after fecal microbiota transplantation

(2016) Simone S. Li et al.   SCIENCE

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease

(2016) G. Hoarau et al.   mBio

Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem?

(2016) Alexis Mosca et al.   Frontiers in Microbiology

Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses

(2016) Oriana Rossi et al.   Scientific Reports

Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis

(2015) V. Gupta et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases

(2015) R. B. Sartor   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice

(2015) Emily A. Sawin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease

(2015) Jason M. Norman et al.   CELL

Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn’s Disease

(2015) James D. Lewis et al.   Cell Host & Microbe

The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's Disease

(2015) Richard N. Fedorak et al.   Clinical Gastroenterology and Hepatology

Editorial Board

(2015)   GASTROENTEROLOGY

Comparative Efficacy of Pharmacologic Interventions in Preventing Relapse of Crohn’s Disease After Surgery: A Systematic Review and Network Meta-analysis

(2015) Siddharth Singh et al.   GASTROENTEROLOGY

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

(2015) Noortje G. Rossen et al.   GASTROENTEROLOGY

Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases

(2015) Dale Lee et al.   GASTROENTEROLOGY

Siblings of patients with Crohn’s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities

(2015) Charlotte Hedin et al.   GUT

Identification of an anti-inflammatory protein fromFaecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease

(2015) E Quévrain et al.   GUT

Alterations of the Subgingival Microbiota in Pediatric Crohnʼs Disease Studied Longitudinally in Discovery and Validation Cohorts

(2015) Judith Kelsen et al.   INFLAMMATORY BOWEL DISEASES

Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohnʼs Disease

(2015) David L. Suskind et al.   INFLAMMATORY BOWEL DISEASES

Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease

(2015) Severine Vermeire et al.   Journal of Crohns & Colitis

Use of antibiotics in patients with Crohn's disease: A systematic review and meta-analysis

(2015) Jie Wen Su et al.   Journal of Digestive Diseases

No Vacancy: How Beneficial Microbes Cooperate with Immunity To Provide Colonization Resistance to Pathogens

(2015) Martina Sassone-Corsi et al.   JOURNAL OF IMMUNOLOGY

Microbial cocktails join fecal transplants in IBD treatment trials

(2015) Mark Ratner   NATURE BIOTECHNOLOGY

Drugging the gut microbiome

(2015) Ken Garber   NATURE BIOTECHNOLOGY

Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis

(2015) Christopher J. Damman et al.   PLoS One

The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis

(2015) Asuka Yasueda et al.   SURGERY TODAY

Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis

(2015) Yasushi Yoshimatsu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Site-Specific Immunomodulator: A Novel Treatment for Crohn’s Disease

(2015) Brian Bressler et al.   Gastroenterology Research and Practice

Gut Microbiota-Produced Succinate Promotes C. difficile Infection after Antibiotic Treatment or Motility Disturbance

(2014) Jessica A. Ferreyra et al.   Cell Host & Microbe

The Treatment-Naive Microbiome in New-Onset Crohn’s Disease

(2014) Dirk Gevers et al.   Cell Host & Microbe

Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results

(2014) Bota Cui et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile

(2014) Charlie G. Buffie et al.   NATURE

Identifying Gut Microbe-Host Phenotype Relationships Using Combinatorial Communities in Gnotobiotic Mice

(2014) J. J. Faith et al.   Science Translational Medicine

A Single Strain of Clostridium butyricum Induces Intestinal IL-10-Producing Macrophages to Suppress Acute Experimental Colitis in Mice

(2013) Atsushi Hayashi et al.   Cell Host & Microbe

Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease

(2013) Kevin Whelan et al.   CURRENT OPINION IN GASTROENTEROLOGY

An update on the use and investigation of probiotics in health and disease

(2013) Mary Ellen Sanders et al.   GUT

Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis

(2013) Lionel Rigottier-Gois   ISME Journal

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

(2013) Yukihiro Furusawa et al.   NATURE

Bacterial colonization factors control specificity and stability of the gut microbiota

(2013) S. Melanie Lee et al.   NATURE

Diet rapidly and reproducibly alters the human gut microbiome

(2013) Lawrence A. David et al.   NATURE

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

(2013) Koji Atarashi et al.   NATURE

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

(2013) P. M. Smith et al.   SCIENCE

Metabolic Profiling of the Impact of Oligofructose-Enriched Inulin in Crohn’s Disease Patients: A Double-Blinded Randomized Controlled Trial

(2013) Vicky De Preter et al.   Clinical and Translational Gastroenterology

Lactocepin Secreted By Lactobacillus Exerts Anti-Inflammatory Effects By Selectively Degrading Proinflammatory Chemokines

(2012) Marie-Anne von Schillde et al.   Cell Host & Microbe

Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model

(2012) Pieter Van den Abbeele et al.   ISME Journal

Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population

(2012) Wesley Leung et al.   Journal of Crohns & Colitis

Diversity, stability and resilience of the human gut microbiota

(2012) Catherine A. Lozupone et al.   NATURE

A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases

(2012) Marina L. Ritchie et al.   PLoS One

Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease

(2012) SHENG-LAN WANG et al.   Experimental and Therapeutic Medicine

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis

(2011) S. Oliva et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

(2011) Khurram J Khan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Current Strategies in the Management of Intra-abdominal Abscesses in Crohn's Disease

(2011) Linda A. Feagins et al.   Clinical Gastroenterology and Hepatology

Beneficial Effects of Probiotic Bifidobacterium and Galacto-Oligosaccharide in Patients with Ulcerative Colitis: A Randomized Controlled Study

(2011) Hideki Ishikawa et al.   DIGESTION

Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial: Table 1

(2011) Marie Joossens et al.   GUT

Alterations in the gut microbiome of children with severe ulcerative colitis

(2011) Sonia Michail et al.   INFLAMMATORY BOWEL DISEASES

Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism

(2011) Fang Yan et al.   JOURNAL OF CLINICAL INVESTIGATION

Bifidobacteria can protect from enteropathogenic infection through production of acetate

(2011) Shinji Fukuda et al.   NATURE

Probiotic-Derived Polyphosphate Enhances the Epithelial Barrier Function and Maintains Intestinal Homeostasis through Integrin–p38 MAPK Pathway

(2011) Shuichi Segawa et al.   PLoS One

Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid

(2011) M. Mohamadzadeh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes

(2011) G. D. Wu et al.   SCIENCE

Review article: medical, surgical and radiological management of perianal Crohn’s fistulas

(2010) P. J. Tozer et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn’s disease

(2010) H. Steed et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Newly Developed Antibiotic Combination Therapy for Ulcerative Colitis: A Double-Blind Placebo-Controlled Multicenter Trial

(2010) Toshifumi Ohkusa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Production of an antibacterial substance in the digestive tract involved in colonization-resistance against Clostridium perfringens

(2010) E.H. Crost et al.   ANAEROBE

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

(2010) Harald Matthes et al.   BMC Complementary and Alternative Medicine

Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis

(2010) Renata D’Incà et al.   DIGESTIVE DISEASES AND SCIENCES

Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system

(2010) Simone Maccaferri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A human gut microbial gene catalogue established by metagenomic sequencing

(2010) Junjie Qin et al.   NATURE

The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties

(2010) Natividad Garrido-Mesa et al.   PHARMACOLOGICAL RESEARCH

Gut Microbiota in Health and Disease

(2010) Inna Sekirov et al.   PHYSIOLOGICAL REVIEWS

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

(2010) J. L. Round et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

(2010) K. Atarashi et al.   SCIENCE

Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet

(2010) Mitsuro Chiba   WORLD JOURNAL OF GASTROENTEROLOGY

Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

(2009) Erasmo Miele et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Towards the human intestinal microbiota phylogenetic core

(2009) Julien Tap et al.   ENVIRONMENTAL MICROBIOLOGY

Perianal fistulae in Crohnʼs Disease: Current and future approaches to treatment

(2009) Hussila Keshaw et al.   INFLAMMATORY BOWEL DISEASES

Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers

(2009) Thai Hoa Joeres-Nguyen-Xuan et al.   INFLAMMATORY BOWEL DISEASES

A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis

(2009) Shunji Fujimori et al.   NUTRITION

Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii

(2008) Carlett Ramirez-Farias et al.   BRITISH JOURNAL OF NUTRITION

The Safety of Probiotics

(2008) David R. Snydman   CLINICAL INFECTIOUS DISEASES

Dietary modulation of peroxisome proliferator-activated receptor gamma

(2008) R Marion-Letellier et al.   GUT

Probiotic administration in patients with ileal pouch–anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells

(2008) Annamaria Pronio et al.   INFLAMMATORY BOWEL DISEASES

A core gut microbiome in obese and lean twins

(2008) Peter J. Turnbaugh et al.   NATURE

Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria

(2008) Jerry M. Wells et al.   NATURE REVIEWS MICROBIOLOGY